Financial Ratios Globe Life Inc.

Equities

GL

US37959E1029

Life & Health Insurance

Market Closed - Nyse Other stock markets 01:30:02 18/04/2026 am IST			5-day change	1st Jan Change
151.86 ^USD	+1.46%		+3.03%	+8.58%

15/04	Oklo Inc. Announces Changes to Its Board of Directors and Management Team to Support Its Continued Growth	CI
09/04	Wells Fargo Adjusts Price Target on Globe Life to $172 From $171, Maintains Overweight Rating	MT

c2630823f11ccede0944b042.d2YLYMlCL4oDSq794On8KegWMB3Ikym05Wr2wTFkOoI.BDJ9M4t6AsBGOMy2rNqTbN9HYiS43RHFhi2Y8HQzT_gxUjoipxJm4Uka2Q

Published financial data: GLOBE LIFE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	409.99Cr	430.27Cr	445.6Cr	466.63Cr	489.02Cr
Total Interest And Dividend Income	95Cr	99Cr	105.69Cr	113.56Cr	113.02Cr
Gain (Loss) on Sale of Investments, Total (Rev)	5.93Cr	-7.65Cr	-6.57Cr	-2.42Cr	-2.78Cr
Other Revenues, Total	12.16L	12.46L	3L	4L	16.88L
Total Revenues	511.29Cr	521.49Cr	544.75Cr	577.81Cr	599.43Cr
Policy Benefits	285.96Cr	286.55Cr	286.43Cr	289.44Cr	288.43Cr
Policy Acquisition / Underwriting Costs, Total	94Cr	100Cr	92Cr	100Cr	108.34Cr
Selling General & Admin Expenses, Total	1Cr	94L	1.92Cr	1.57Cr	71L
Stock-Based Compensation (IS)	3.03Cr	3.56Cr	3.07Cr	4.01Cr	5.34Cr
Other Operating Expenses	27Cr	31Cr	32Cr	36Cr	37Cr
Total Operating Expenses	410.89Cr	421.57Cr	415.01Cr	430.28Cr	440.01Cr
Operating Income	100.4Cr	100Cr	129.75Cr	147.53Cr	159.42Cr
Interest Expense, Total	-8.35Cr	-9.04Cr	-10Cr	-13Cr	-14Cr
EBT, Excl. Unusual Items	92Cr	91Cr	119.52Cr	134.82Cr	145.3Cr
Legal Settlements	-81.39L	-24.96L	-9L	-2.16Cr	-1.71Cr
EBT, Incl. Unusual Items	91Cr	91Cr	119.43Cr	132.66Cr	143.6Cr
Income Tax Expense	17Cr	17Cr	22Cr	26Cr	27Cr
Earnings From Continuing Operations	74Cr	74Cr	97Cr	107.08Cr	116.12Cr
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	74Cr	74Cr	97Cr	107.08Cr	116.12Cr
Net Income - (IS)	74Cr	74Cr	97Cr	107.08Cr	116.12Cr
Net Income to Common Incl Extra Items	74Cr	74Cr	97Cr	107.08Cr	116.12Cr
Net Income to Common Excl. Extra Items	74Cr	74Cr	97Cr	107.08Cr	116.12Cr
Per Share Items
Net EPS - Basic	7.3	7.55	10.21	11.99	14.27
Basic EPS - Continuing Operations	7.3	7.55	10.21	11.99	14.27
Basic Weighted Average Shares Outstanding	10Cr	9.79Cr	9.51Cr	8.93Cr	8.14Cr
Net EPS - Diluted	7.22	7.47	10.07	11.94	14.07
Diluted EPS - Continuing Operations	7.22	7.47	10.07	11.94	14.07
Diluted Weighted Average Shares Outstanding	10Cr	9.9Cr	9.64Cr	8.97Cr	8.25Cr
Normalized Basic EPS	5.64	5.8	7.85	9.44	11.16
Normalized Diluted EPS	5.58	5.74	7.75	9.4	11
Dividend Per Share	0.79	0.83	0.9	0.96	1.08
Payout Ratio	10.74	10.89	8.66	7.98	7.41
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	102.4Cr	102.02Cr	131.85Cr	150.23Cr	162.42Cr
EBITA	100.4Cr	100Cr	129.75Cr	147.53Cr	159.42Cr
EBIT	100.4Cr	100Cr	129.75Cr	147.53Cr	159.42Cr
EBITDAR	102.87Cr	102.44Cr	132.2Cr	150.55Cr	162.77Cr
Total Revenues (As Reported)	511.29Cr	521.49Cr	544.75Cr	577.81Cr	599.43Cr
Effective Tax Rate - (Ratio)	18.35	18.38	18.72	19.29	19.13
Current Domestic Taxes	-	-	-	-	20Cr
Total Current Taxes	14Cr	14Cr	15Cr	22Cr	20Cr
Deferred Domestic Taxes	-	-	-	-	7.75Cr
Total Deferred Taxes	2.27Cr	2.84Cr	7.76Cr	3.77Cr	7.75Cr
Normalized Net Income	58Cr	57Cr	75Cr	84Cr	91Cr
Interest on Long-Term Debt	7.82Cr	8.05Cr	8.03Cr	9.11Cr	11Cr
Non-Cash Pension Expense	1.01Cr	24.16L	-63.43L	-84.4L	-89.85L
Supplemental Operating Expense Items
Advertising Expense	1Cr	94L	1.92Cr	1.57Cr	71L
Selling and Marketing Expenses	1Cr	94L	1.92Cr	1.57Cr	71L
Net Rental Expense, Total	46.74L	42.39L	35.19L	32.08L	34.94L
Imputed Operating Lease Interest Expense	15.81L	14.94L	13.23L	12.16L	12.79L
Imputed Operating Lease Depreciation	30.93L	27.45L	21.96L	19.92L	22.15L
Stock-Based Comp., Other (Total)	3.03Cr	3.56Cr	3.07Cr	4.01Cr	5.34Cr
Total Stock-Based Compensation	3.03Cr	3.56Cr	3.07Cr	4.01Cr	5.34Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Investment In Debt Securities	2.13TCr	1.65TCr	1.79TCr	1.72TCr	1.76TCr
Investment In Equity and Preferred Securities, Total	54Cr	65Cr	65Cr	69Cr	97Cr
Mortgage Loans	57Cr	61Cr	69Cr	96Cr	104.26Cr
Policy Loans	59Cr	61Cr	66Cr	70Cr	74Cr
Total Other Investments	8.1Cr	14Cr	12Cr	13Cr	36Cr
Total investments	2.31TCr	1.85TCr	2TCr	1.96TCr	2.07TCr
Cash And Equivalents	9.22Cr	9.26Cr	10Cr	17Cr	14Cr
Other Receivables - (Insurance Template)	74Cr	74Cr	90Cr	96Cr	104.14Cr
Deferred Policy Acquisition Costs - (BS)	491.47Cr	524.99Cr	600.95Cr	649.56Cr	699.91Cr
Gross Property Plant And Equipment	38Cr	41Cr	46Cr	53Cr	62Cr
Accumulated Depreciation	-17Cr	-19Cr	-22Cr	-24Cr	-24Cr
Net Property Plant And Equipment	20Cr	21Cr	24Cr	28Cr	37Cr
Goodwill	48Cr	48Cr	48Cr	49Cr	49Cr
Other Current Assets, Total	-	-	-	-	-
Other Long-Term Assets, Total	25Cr	23Cr	33Cr	103.93Cr	106.57Cr
Total Assets	2.98TCr	2.55TCr	2.81TCr	2.91TCr	3.08TCr
Liabilities
Insurance And Annuity Liabilities	1.61TCr	1.68TCr	1.96TCr	1.86TCr	1.93TCr
Unpaid Claims	41Cr	43Cr	51Cr	53Cr	54Cr
Unearned Premiums	6.55Cr	6.07Cr	25Cr	26Cr	27Cr
Current Portion of Long-Term Debt	15Cr	17Cr	17Cr	-	-
Current Portion of Leases	-	-	-	-	-
Short-Term Borrowings	33Cr	28Cr	32Cr	42Cr	30Cr
Long-Term Debt	110.59Cr	118.73Cr	132.68Cr	225.54Cr	231.69Cr
Long-Term Leases	-	-	-	-	-
Trust Preferred Securities (BS)	44Cr	44Cr	44Cr	44Cr	44Cr
Current Income Taxes Payable	176.5Cr	69Cr	49Cr	73Cr	86Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	-
Deferred Tax Liability Non-Current	-	-	-	-	-
Other Non Current Liabilities	72Cr	54Cr	49Cr	58Cr	84Cr
Total Liabilities	2.11TCr	2.06TCr	2.36TCr	2.38TCr	2.48TCr
Common Stock, Total	11Cr	11Cr	10Cr	9.72Cr	9.22Cr
Additional Paid In Capital	52Cr	53Cr	53Cr	53Cr	54Cr
Retained Earnings	618.21Cr	646.62Cr	747.88Cr	800.25Cr	854.68Cr
Treasury Stock	-85Cr	-79Cr	-85Cr	-129.23Cr	-142.94Cr
Comprehensive Income and Other	267.76Cr	-141.57Cr	-277.24Cr	-202.97Cr	-177.14Cr
Total Common Equity	864.28Cr	489.59Cr	448.68Cr	530.55Cr	597.46Cr
Total Equity	864.28Cr	489.59Cr	448.68Cr	530.55Cr	597.46Cr
Total Liabilities And Equity	2.98TCr	2.55TCr	2.81TCr	2.91TCr	3.08TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.93Cr	9.65Cr	9.37Cr	8.38Cr	7.86Cr
ECS Total Common Shares Outstanding	9.96Cr	9.67Cr	9.38Cr	8.4Cr	7.91Cr
Book Value / Share	86.8	50.61	47.84	63.18	75.54
Tangible Book Value	816.1Cr	441.41Cr	400.5Cr	481.51Cr	548.41Cr
Tangible Book Value Per Share	81.96	45.63	42.7	57.34	69.34
Total Debt	202.61Cr	207.71Cr	225.37Cr	311.17Cr	306.24Cr
Net Debt	193.4Cr	198.45Cr	215.05Cr	294.63Cr	291.77Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	18Cr	6.28Cr	5.68Cr	2.02Cr	-24.34L
Debt Equivalent Oper. Leases	3.74Cr	3.39Cr	2.82Cr	2.57Cr	2.8Cr
Equity Method Investments, Total	33Cr	32Cr	27Cr	27Cr	48Cr
Account Code - Inventory Valuation	3	3	-	3	3
Full Time Employees	3.22T	3.54T	3.64T	3.73T	3.7T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	74Cr	74Cr	97Cr	107.08Cr	116.12Cr
Depreciation, Depletion & Amortization	2Cr	2.1Cr	2.1Cr	2.7Cr	3Cr
Total Depreciation, Depletion & Amortization	2Cr	2.1Cr	2.1Cr	2.7Cr	3Cr
(Gain) Loss on Sale of Investments - (CF)	-5.93Cr	7.65Cr	6.57Cr	2.42Cr	2.78Cr
Amort. Of Deferred Policy Acq. Costs - (CF)	60Cr	62Cr	38Cr	41Cr	45Cr
Change In Income Taxes	7.19Cr	5.07Cr	10Cr	7.79Cr	9.89Cr
Change in insurance Reserves / Liabilities	87Cr	86Cr	84Cr	75Cr	60Cr
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities	-82Cr	-95Cr	-90Cr	-96Cr	-97Cr
Cash from Operations	143.77Cr	142.22Cr	148.24Cr	140.24Cr	139.64Cr
Capital Expenditure	-3.82Cr	-2.79Cr	-4.96Cr	-7.1Cr	-14Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-81Cr	-89Cr	-72Cr	-41Cr	-39Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-52.55L	-2.52Cr	-16Cr	-16Cr	-12Cr
Other Investing Activities, Total	-5.67Cr	-	-	96T	-
Cash from Investing	-91Cr	-94Cr	-93Cr	-64Cr	-64Cr
Short Term Debt Issued, Total	7.5Cr	-	3.3Cr	48Cr	59Cr
Long-Term Debt Issued, Total	32Cr	25Cr	17Cr	53Cr	-
Total Debt Issued	40Cr	25Cr	20Cr	101.47Cr	59Cr
Short Term Debt Repaid, Total	-	-4.63Cr	-	-39Cr	-70Cr
Long-Term Debt Repaid, Total	-30Cr	-15Cr	-17Cr	-	-
Total Debt Repaid	-30Cr	-20Cr	-17Cr	-39Cr	-70Cr
Issuance of Common Stock	6.98Cr	11Cr	11Cr	5.18Cr	16Cr
Repurchase of Common Stock	-54Cr	-45Cr	-51Cr	-100.21Cr	-88Cr
Common Dividends Paid	-8Cr	-8.05Cr	-8.41Cr	-8.55Cr	-8.61Cr
Common & Preferred Stock Dividends Paid	-8Cr	-8.05Cr	-8.41Cr	-8.55Cr	-8.61Cr
Annuity Receipts	-	-	-	11Cr	15Cr
Annuity Payments	-6.42Cr	-11Cr	-9.69Cr	-	-
Other Financing Activities, Total	-76.87L	-52.72L	-8L	-42Cr	-63.99L
Cash from Financing	-52Cr	-49Cr	-54Cr	-72Cr	-77Cr
Foreign Exchange Rate Adjustments	-33.91L	1.37Cr	-41.92L	1.71Cr	-53.42L
Net Change in Cash	-26.84L	4L	1.06Cr	6.22Cr	-2.06Cr
Supplemental Items
Cash Interest Paid	8.31Cr	8.88Cr	9.95Cr	12Cr	14Cr
Cash Income Tax Paid (Refund)	9.62Cr	11Cr	12Cr	18Cr	18Cr
Net Debt Issued / Repaid	10Cr	5.42Cr	3.73Cr	63Cr	-11Cr
Levered Free Cash Flow	116.27Cr	10Cr	117.61Cr	144.2Cr	113.68Cr
Unlevered Free Cash Flow	121.49Cr	16Cr	124Cr	152.14Cr	122.51Cr
Change In Net Working Capital	2.85Cr	111.72Cr	-4.72Cr	-19Cr	16Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.13	2.26	3	3.23	3.33
Return on Total Capital	5.87	7.08	12.68	12.17	11.42
Return On Equity %	8.56	10.93	23.01	21.87	20.59
Return on Common Equity	8.56	10.93	23.01	21.87	20.59
Margin Analysis
Gross Profit Margin %	25.78	25.9	30.54	32.69	33.81
SG&A Margin	0.2	0.18	0.35	0.27	0.12
EBITDA Margin %	20.03	19.56	24.2	26	27.1
EBITA Margin %	19.64	19.16	23.82	25.53	26.6
EBIT Margin %	19.64	19.16	23.82	25.53	26.6
Income From Continuing Operations Margin %	14.57	14.18	17.82	18.53	19.37
Net Income Margin %	14.57	14.18	17.82	18.53	19.37
Net Avail. For Common Margin %	14.57	14.18	17.82	18.53	19.37
Normalized Net Income Margin	11.25	10.89	13.71	14.58	15.15
Levered Free Cash Flow Margin	22.74	1.99	21.59	24.96	18.96
Unlevered Free Cash Flow Margin	23.76	3.08	22.76	26.33	20.44
Asset Turnover
Asset Turnover	0.17	0.19	0.2	0.2	0.2
Fixed Assets Turnover	26.15	25.01	24.1	22.01	18.3
Short Term Liquidity
Current Ratio	0.33	0.58	0.62	0.63	0.76
Quick Ratio	0.24	0.43	0.47	0.49	0.62
Operating Cash Flow to Current Liabilities	0.53	0.87	0.85	0.72	0.71
Average Days Payable Outstanding	39.07	39.81	49.4	49.29	49.39
Long Term Solvency
Total Debt/Equity	23.44	42.42	50.23	58.65	51.26
Total Debt / Total Capital	18.99	29.79	33.43	36.97	33.89
LT Debt/Equity	17.89	33.25	39.39	50.82	46.16
Long-Term Debt / Total Capital	14.5	23.35	26.22	32.03	30.52
Total Liabilities / Total Assets	70.97	80.83	84.01	81.75	80.61
EBIT / Interest Expense	12.03	11.05	12.68	11.61	11.29
EBITDA / Interest Expense	12.27	11.29	12.89	11.82	11.5
(EBITDA - Capex) / Interest Expense	11.81	10.98	12.4	11.26	10.49
Total Debt / EBITDA	1.98	2.04	1.71	2.07	1.89
Net Debt / EBITDA	1.89	1.95	1.63	1.96	1.8
Total Debt / (EBITDA - Capex)	2.06	2.09	1.78	2.17	2.07
Net Debt / (EBITDA - Capex)	1.96	2	1.69	2.06	1.97
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.91	2	4.22	6.07	3.74
Gross Profit, 1 Yr. Growth %	2.61	2.49	6.93	13.52	7.31
EBITDA, 1 Yr. Growth %	2.03	-0.37	8.43	13.94	8.12
EBITA, 1 Yr. Growth %	1.76	-0.48	8.58	13.71	8.06
EBIT, 1 Yr. Growth %	1.76	-0.48	8.58	13.71	8.06
Earnings From Cont. Operations, 1 Yr. Growth %	1.8	-0.71	8.54	10.3	8.45
Net Income, 1 Yr. Growth %	1.8	-0.71	8.54	10.3	8.45
Normalized Net Income, 1 Yr. Growth %	2.29	-1.27	8.2	12.81	7.77
Diluted EPS Before Extra, 1 Yr. Growth %	5.87	3.46	11.39	18.57	17.84
Net Property, Plant and Equip., 1 Yr. Growth %	10.22	3.41	13.21	18.75	29.82
Total Assets, 1 Yr. Growth %	2.48	-14.21	7.95	3.65	5.98
Common Equity, 1 Yr. Growth %	-1.46	-43.35	13.6	18.25	12.61
Tangible Book Value, 1 Yr. Growth %	-2.02	-45.91	15.49	20.23	13.9
Cash From Operations, 1 Yr. Growth %	-2.62	-1.08	4.24	-5.4	-0.43
Capital Expenditures, 1 Yr. Growth %	-8.41	-26.97	77.42	43.37	100.55
Levered Free Cash Flow, 1 Yr. Growth %	-18.83	-91.06	-983.47	22.61	-21.16
Unlevered Free Cash Flow, 1 Yr. Growth %	-18.28	-86.79	-1.72T	22.69	-19.48
Dividend Per Share, 1 Yr. Growth %	5.33	5.06	8.43	6.67	12.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.27	4.91	3.23	5.14	4.9
Gross Profit, 2 Yr. CAGR %	-0.09	2.55	-0.79	10.17	10.37
EBITDA, 2 Yr. CAGR %	-0.77	0.82	-2.47	11.15	10.99
EBITA, 2 Yr. CAGR %	-0.98	0.63	-2.55	11.11	10.85
EBIT, 2 Yr. CAGR %	-0.98	0.63	-2.55	11.11	10.85
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.05	0.54	-2.97	9.42	9.37
Net Income, 2 Yr. CAGR %	-1.05	0.54	-2.97	9.42	9.37
Normalized Net Income, 2 Yr. CAGR %	-1.02	0.49	-3.47	10.48	10.26
Diluted EPS Before Extra, 2 Yr. CAGR %	2.82	4.66	0.4	14.93	18.2
Net Property, Plant and Equip., 2 Yr. CAGR %	12.84	6.76	8.2	15.95	24.16
Total Assets, 2 Yr. CAGR %	7.05	-6.24	-2.93	5.78	4.81
Common Equity, 2 Yr. CAGR %	8.85	-25.29	-27.95	15.9	15.39
Tangible Book Value, 2 Yr. CAGR %	9.13	-27.2	-29.95	17.84	17.02
Cash From Operations, 2 Yr. CAGR %	2.67	-1.85	1.54	-0.7	-2.95
Capital Expenditures, 2 Yr. CAGR %	-4.81	-18.22	13.83	59.49	69.57
Levered Free Cash Flow, 2 Yr. CAGR %	-33.94	-73.06	3.26	229.12	-1.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	-33.13	-67.15	3.61	345.59	-0.61
Dividend Per Share, 2 Yr. CAGR %	7	5.2	6.74	7.55	9.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.91	4.82	4.76	4.17	4.67
Gross Profit, 3 Yr. CAGR %	2.24	0.76	9.01	3.77	9.21
EBITDA, 3 Yr. CAGR %	1.94	-0.64	9.52	2.72	10.13
EBITA, 3 Yr. CAGR %	1.73	-0.81	9.56	2.59	10.09
EBIT, 3 Yr. CAGR %	1.73	-0.81	9.56	2.59	10.09
Earnings From Cont. Operations, 3 Yr. CAGR %	2.02	-0.94	9.88	1.27	9.09
Net Income, 3 Yr. CAGR %	2.03	-0.93	9.88	1.27	9.09
Normalized Net Income, 3 Yr. CAGR %	2.15	-1.11	9.92	1.67	9.57
Diluted EPS Before Extra, 3 Yr. CAGR %	5.84	3.03	13.87	6.12	15.89
Net Property, Plant and Equip., 3 Yr. CAGR %	14.94	9.61	8.87	11.61	20.4
Total Assets, 3 Yr. CAGR %	8.83	-0.57	-1.16	-0.78	5.84
Common Equity, 3 Yr. CAGR %	16.86	-12.44	-20.02	-15.01	14.79
Tangible Book Value, 3 Yr. CAGR %	17.95	-13.64	-21.66	-16.13	16.51
Cash From Operations, 3 Yr. CAGR %	4.01	1.41	0.14	-0.82	-0.61
Capital Expenditures, 3 Yr. CAGR %	-5.34	-12.86	5.87	22.93	72.15
Levered Free Cash Flow, 3 Yr. CAGR %	1.43	-66.08	-6.36	9.35	104.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.25	-61.06	-5.87	9.62	151.92
Dividend Per Share, 3 Yr. CAGR %	7.27	6.35	6.27	6.71	9.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.38	4.65	4.83	5	4.82
Gross Profit, 5 Yr. CAGR %	3.92	2.87	6.17	7.42	9.55
EBITDA, 5 Yr. CAGR %	3.42	1.95	6.4	7.63	10.11
EBITA, 5 Yr. CAGR %	3.25	1.77	6.35	7.58	10.07
EBIT, 5 Yr. CAGR %	3.25	1.77	6.35	7.58	10.07
Earnings From Cont. Operations, 5 Yr. CAGR %	6.66	-12.69	6.71	7.07	9.68
Net Income, 5 Yr. CAGR %	6.26	-12.65	6.71	7.07	9.68
Normalized Net Income, 5 Yr. CAGR %	3.58	1.81	6.71	7.49	10.06
Diluted EPS Before Extra, 5 Yr. CAGR %	10.36	-9.43	10.58	11.82	15.59
Net Property, Plant and Equip., 5 Yr. CAGR %	16.14	14.44	12.2	12.1	14.75
Total Assets, 5 Yr. CAGR %	6.79	1.7	3.96	2.28	1.19
Common Equity, 5 Yr. CAGR %	13.61	-4.71	-3.69	-6.17	-7.39
Tangible Book Value, 5 Yr. CAGR %	14.62	-5.28	-4.24	-6.81	-8.02
Cash From Operations, 5 Yr. CAGR %	0.55	-0.1	3.02	0.56	-1.11
Capital Expenditures, 5 Yr. CAGR %	8.73	6.6	1.9	10.98	27.82
Levered Free Cash Flow, 5 Yr. CAGR %	-3.24	-31.03	1.09	-11.55	-4.52
Unlevered Free Cash Flow, 5 Yr. CAGR %	-3.11	-23.52	1.16	-10.95	-3.8
Dividend Per Share, 5 Yr. CAGR %	7.12	6.71	7.06	6.83	7.57